The deadline to respond to the 2025 Pressures Survey has been extended to Monday 10th March. We really want to hear from even more voices across the sector, as your views and first-hand experiences make all the difference in working towards delivering a stronger future for community pharmacy. The Pressures Survey continues to be a
Read moreFollowing discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (27/02/2025) announced the following list of price concessions for February 2025: Please note: Following a mid-month price increase reported by pharmacy owners, Community Pharmacy England has secured an
Read moreCommunity Pharmacy England met in London for a full Committee Meeting on 5th and 6th February 2025. Committee discussions covered key topics including in-depth consideration of the 2024/25 and 2025/26 negotiations, as well as Community Pharmacy England’s budget, levy and workplans for the coming financial year. The Committee also considered ongoing matters relating to governance
Read more
MHRA Class 4 Medicines Notification: Lansoprazole Gastro-resistant Hard Capsules 15mg (Teva UK Limited) Drug alert number: EL(25)A/06 Date issued: 11 February 2025 Teva UK Limited is reporting a minor typographical error on the carton for Lansoprazole Gastro-Resistant Hard Capsules 15mg. There are two instances where the dosage form is stated as “tablets” where it should state
Read moreFollowing representations made by Community Pharmacy England on behalf of community pharmacy owners, the Department of Health and Social Care (DHSC) has retrospectively adjusted the reimbursement prices of certain products dispensed in October and November 2024. Under the current price change mechanism, pharmacy owners would have to wait one (or in some cases two months) before any NHS list prices changes are applied to
Read moreCommunity Pharmacy England is reminding pharmacy teams about which EPS tokens need to be submitted. The EPS tokens that are required to be sent to the NHSBSA for end-of-month submission are: EPS tokens used to capture the paid or exemption declaration. Pharmacy First related EPS tokens, where medicines or appliances were supplied as part of
Read moreThis factsheet sets out for pharmacy teams which EPS tokens are required to be submitted alongside the paper prescription bundle at the end of each month to the NHSBSA. Briefing 005/25 EPS token submission The post Briefing 005/25: EPS token submission appeared first on Community Pharmacy England.
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Quetiapine 50mg, 150mg, 200mg, 300mg and 400mg modified-release tablets MSN/2025/006 Tier 2 medium impact Date of issue: 10th February 2025 There are supply constraints affecting quetiapine 50mg, 150mg, 200mg, 300mg and 400mg modified-release tablets (see supply summary table in Supporting information).
Read moreThe NHS Business Services Authority (NHSBSA) produces a quarterly newsletter called “Hints & Tips for dispensing contractors”. The latest edition (Issue 58) contains some useful information and advice on: Tax credits to end on Saturday 5 April 2025 Pharmacy First – completing a supply within the Patient Group Direction (PGD) Endorsing Not Dispensed items Real
Read moreDrug alert number: EL (25)A/05 Date issued: 5 February 2025 CNX Therapeutics is recalling the batches listed in this notification as a precautionary measure due to a small number of packs that contain an additional tablet of Nitrofurantoin. The registered product is a capsule containing powder and two yellow tablets. Nitrofurantoin 100 mg Prolonged-Release capsules
Read more
